Fintel reports that on July 16, 2025, B of A Securities downgraded their outlook for Centene (NYSE:CNC) from Neutral to ...

Centene Corporation (NYSE:CNC) is one of the Best Beaten Down Stocks to Buy Now. Bank of America downgraded the company’s stock to “Underperform” from “Neutral,” reducing the price objective to $30 ...

Investing.com -- Shares of Centene (NYSE:CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance, citing unexpectedly poor risk adjustment results in ...

Investing.com - UBS downgraded Centene (NYSE:CNC) stock rating from Buy to Neutral on Wednesday, slashing its price target to $45.00 from $80.00 following the healthcare company’s withdrawal of ...

On June 2, an analyst from Barclays downgraded Centene Corporation’s (NYSE:CNC) rating from Overweight to Equal-Weight and lowered its price target from $84 to $65. The downgrade follows Centene ...

Argus downgraded Centene (NYSE:CNC) to Hold from Buy on Thursday, citing the Medicaid-focused insurer’s recent Q4 2024 results and projecting an uncertain outlook for the company’s operations ...

Jefferies downgraded Centene (CNC) to Underperform from Hold with a price target of $52, down from $68. After analysis of Affordable Care Act Exchange data, the firm sees potential for ...

Humana, Elevance, Centene downgraded days before second-quarter earnings kickoff Major payers are facing downgrades amid rising Medicare Advantage and commercial cost pressures. Published July 13 ...

As of March 9, 2023, the average one-year price target for Centene is $93.90. The forecasts range from a low of $79.79 to a high of $115.50. The average price target represents an increase of 40. ...

This revision was in response to Centene's slight increase in its 2024 EPS guidance by approximately 1.5%, despite a roughly 0.40% miss in the Medicaid Medical Loss Ratio.